Whatnot raised $545M at a $20 billion valuation, doubling in ten months while Silicon Valley chases AI. Here's the math behind live shopping's biggest round.
Neros just raised $250M at a $2.5B valuation—roughly triple its worth nine months ago—to scale toward a million American-made drones a year by 2028.
After two rejections, Replimune's tumor-injected virus Tudriqev won accelerated FDA approval on August 6 — a 24.2% response rate in melanoma that had beaten standard immunotherapy.
Valar Atomics raised $1B from Sequoia at a $6B valuation to mass-produce small nuclear reactors for AI data centers. Its founder dropped out of high school at 16.
OpenAI made free ChatGPT unlimited on GPT-5.6 Luna and says GPT-5.6 Sol cuts factual errors 68% versus GPT-5.5 Instant.
DeepSeek went out for about $7 billion and investors came back with at least $12 billion, in a Tencent- and CATL-led round ahead of a planned 2027 IPO.
🔥 Gigabyte Just Dropped a $400 WOLED Gaming Monitor and It Changes Everything...
The AI chip company Cerebras Systems — the most prominent challenger to Nvidia's GPU empire — hit the Nasdaq on Thursday under the ticker CBRS and...
> In 2025, startups discovered AI. In 2026, the winners figured out which tools to use and when. Here's the stack the smartest founders are runni...
Bending Spoons is buying Airtable for $1.285 billion in all cash — about 89% below the productivity startup's $11.7B pandemic-era peak, and its first deal since going public.
The FDA just approved FAYUVI, the first-ever treatment for Sanfilippo syndrome type A: a one-time gene therapy from Ultragenyx priced at $3.95 million per patient.
Adicet's off-the-shelf CAR-T put 54% of a small lupus trial into remission on a single dose. Then the stock dropped 22%.
Precision Neuroscience closed an oversubscribed $250M Series D at a ~$1B valuation, betting its surface brain implant beats drilling into tissue.
